Navigation Links
Omnicell Announces First Quarter 2008 Results
Date:4/21/2008

business;

2) Since we have historically reported non-GAAP results to the investment

community, we believe the inclusion of non-GAAP numbers provides

consistency and enhances investors' ability to compare our performance

across financial reporting periods;

3) These non-GAAP financial measures are employed by Omnicell's management

in its own evaluation of performance and are utilized in financial and

operational decision making processes, such as budget planning and

forecasting; and

4) These non-GAAP financial measures facilitate comparisons to the

operating results of other companies in our industry, which use similar

financial measures to supplement their GAAP results, thus enhancing the

perspective of investors who wish to utilize such comparisons in their

analysis of our performance.

Set forth below are additional reasons why specific items are excluded from our non-GAAP financial measures:

a) While stock-based compensation calculated in accordance with SFAS

No.123R constitutes an ongoing and recurring expense of Omnicell, it is

not an expense which requires cash settlement by Omnicell. We therefore

exclude these charges for purposes of evaluating core operating

results. Thus, our non-GAAP measurements are presented exclusive of

stock-based compensation expenses to assist management and investors in

evaluating our core operating results.

b) We present our reconciliation of non-GAAP financial measures on a net

of tax basis because the exact tax differences related to the timing

and deductibility of stock-based compensation, pursuant to the adoption

of SFAS No. 123R, is dependent upon the trading price of Omnicell's

common stock and the timing and exercise by employees of their stock

options. We analyze and measure operating results n
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Omnicell Schedules First Quarter 2008 Earnings Call
2. Omnicell Announces Completion of Its Common Stock Repurchase Plan
3. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
4. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
5. Omnicell Schedules Fourth Quarter Earnings Call
6. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
7. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
8. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
9. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
10. Omnicell Reports Strong Q3 Revenue and Profit Growth
11. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4ACLU of Illinois Responds to Ruling Reviving the Dormant Illinois Parental Notice of Abortion Act 51689 1Personal Injury Attorneys Contemplate Toxic Evidence in the Death of 3 Men in New York 51686 1Personal Injury Attorneys Contemplate Toxic Evidence in the Death of 3 Men in New York 51686 2Personal Injury Attorneys Contemplate Toxic Evidence in the Death of 3 Men in New York 51686 3Masimo Rad 87 28R 29 Pulse CO Oximeter 28TM 29 Garners Silver 2009 Medical Design Excellence Award 51683 1Masimo Rad 87 28R 29 Pulse CO Oximeter 28TM 29 Garners Silver 2009 Medical Design Excellence Award 51683 2Masimo Rad 87 28R 29 Pulse CO Oximeter 28TM 29 Garners Silver 2009 Medical Design Excellence Award 51683 3Masimo Rad 87 28R 29 Pulse CO Oximeter 28TM 29 Garners Silver 2009 Medical Design Excellence Award 51683 4